Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention.
Giantini A, Timan IS, Dharma R, Sukmawan R, Setiabudy R, Alwi I, Harahap AR, Listiyaningsih E, Partakusuma LG, Tansir AR, Sahar W, Hidayat R. Giantini A, et al. Among authors: setiabudy r. Front Cardiovasc Med. 2023 Feb 8;9:1027892. doi: 10.3389/fcvm.2022.1027892. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36843628 Free PMC article.
PF3 activity in normal subjects and beta-thalassemia trait.
Timan IS, Funahara Y, Setiabudy R, Latu J, Silman E. Timan IS, et al. Among authors: setiabudy r. Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:216-8. Southeast Asian J Trop Med Public Health. 1993. PMID: 7886579
Longer Hydroxyurea Administration Prior to Imatinib Mesylate is Risk Factor for Unsuccessful Major Molecular Response in Chronic-Phase Chronic Myeloid Leukemia: Possibility of P-Glycoprotein Role.
Rinaldi I, Reksodiputro AH, Jusman SW, Harahap A, Setiabudy R, Wanandi SI, Tambunan K, Suharti C. Rinaldi I, et al. Among authors: setiabudy r. Asian Pac J Cancer Prev. 2019 Dec 1;20(12):3689-3695. doi: 10.31557/APJCP.2019.20.12.3689. Asian Pac J Cancer Prev. 2019. PMID: 31870110 Free PMC article.
Circulating miR-10b, soluble urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 as predictors of non-small cell lung cancer progression and treatment response.
Setiawan L, Setiabudy R, Kresno SB, Sutandyo N, Syahruddin E, Jovianti F, Nadliroh S, Mubarika S, Setiabudy R, Siregar NC. Setiawan L, et al. Among authors: setiabudy r. Cancer Biomark. 2024;39(2):137-153. doi: 10.3233/CBM-220222. Cancer Biomark. 2024. PMID: 38073374 Free PMC article.
53 results